Preparation method for biosynthesizing radix pseudostellariae cyclic peptide B in vitro

Through in vitro enzymatic reaction, the linear ginseng ginseng peptide B is converted into cyclic ginseng ginseng peptide B, which solves the problems of complex steps and low purity in the existing technology, and realizes the efficient and environmentally friendly preparation of ginseng ginseng ginseng peptide B. Advantages of rapid response, few side reactions and controllability.

CN119020439APending Publication Date: 2024-11-26GUANGZHOU HUANYA COSMETIC SCI & TECH CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411106074.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In the prior art, the preparation method of the pyrogen gin peptide B is complicated, with low purity and low yield. The biosynthesis method is susceptible to cell activity and complexity when synthesized in vivo, and is often accompanied by the generation of by-products.

Method used

Through in vitro enzymatic reaction, linear genus cyclic peptide B is mixed with cyclic enzyme GmPOPB, the reaction conditions such as temperature and time are controlled, and enzymatic reaction is carried out to obtain cyclic genus cyclic peptide B, and the purity is improved through the removal step.

Benefits of technology

It realizes the large-scale preparation of cyclic genus ginseng B with simple, low cost and short production cycle, which improves the quality and yield of the product, reduces side reactions, and meets the requirements of green and environmental protection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004990847560000121
    Figure BDA0004990847560000121
  • Figure BDA0004990847560000131
    Figure BDA0004990847560000131
  • Figure HDA0004990847570000011
    Figure HDA0004990847570000011
Patent Text Reader

Abstract

The invention belongs to the technical field of biology, and discloses a preparation method of radix pseudostellariae cyclic peptide B. The preparation method comprises the following steps: mixing linear radix pseudostellariae cyclic peptide B and cyclase GmPOPB, and carrying out in-vitro enzymatic reaction to obtain the radix pseudostellariae cyclic peptide B. The invention provides a preparation method for converting linear heterophylly falsestarwort root cyclic peptide B into cyclic heterophylly falsestarwort root cyclic peptide B. The method can effectively solve the technical problems of complex preparation steps, low purity, low yield and the like of the cyclic heterophylly falsestarwort root cyclic peptide B in the prior art. The method can be used for preparing the cyclic pseudostellaria heterophylla cyclic peptide B in a simple, low-cost and short-production-cycle large-scale manner.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and particularly relates to a method for preparing an in vitro biosynthetic Pseudostellaria heterophylla cyclopeptide B. Background Art

[0002] Heterophyllin B (HB) is a representative component of Pseudostellaria heterophylla, a plant of the Caryophyllaceae family. It can inhibit the activity of tyrosinase and reduce the production of melanin in the skin, so it is often used in cosmetics as a whitening or spot-lightening active ingredient. It is a cyclic peptide composed of 8 amino acids, with a specific sequence of Ile-Phe-Gly-Gly-Leu-Pro-Pro-Pro, in which glycine and proline are rich, which are the two most common amino acids in skin collagen. Since the structure of cyclic peptides is connected end to end, it is difficult to synthesize by traditional methods compared with linear peptides. Therefore, the synthesis of cyclic peptides is still difficult and expensive.

[0003] The main methods for obtaining Pseudostellariae cyclopeptide B are natural extraction, chemical synthesis and biosynthesis. The natural extraction method has complex steps, low purity, low yield, and is also susceptible to resource constraints. As described in patent CN109528804A, it is necessary to obtain the total cyclopeptide through the steps of "extraction of Pseudostellariae cyclopeptide-defatting-amino acid removal-alcohol precipitation-freeze drying". If high-purity Pseudostellariae cyclopeptide B is required, the total cyclopeptide needs to be further separated and purified. The chemical synthesis method is mainly solid phase peptide synthesis. Patent CN108218964A describes a method for preparing Pseudostellariae cyclotide B by combining solid phase peptide synthesis with enzyme method. Although this method omits the step of cleaving and purifying the linear peptide after synthesis in the traditional method, the synthesis of solid phase peptide requires a large amount of harmful solvents, which is easy to cause certain pollution to the environment. Patent CN118006700A uses a double hydrophobic carrier "molecular claw" method to synthesize Pseudostellariae cyclotide B. This method first chemically synthesizes compounds of formula I, II, III and IV. The synthesis steps are complicated and require the use of harmful solvents such as dichloromethane, trifluoroacetic acid, etc. The biosynthesis method has the advantages of mild conditions, environmental friendliness and strong specificity, and has great advantages in synthesizing Pseudostellariae cyclotide B. Although the prior art, such as CN116334117A, synthesizes Pseudostellariae cyclotide B in vivo by constructing a pET28a-MBP-TEVsite-TEV-TEVsite-HB-J23100-GmPOPB co-expression vector, its construction steps are numerous, and multiple genes (MBP, TEV, TEVsite and HB sequences, GmPOPB and promoter J23100) need to be connected to the pET28a vector. In addition, the larger vector may affect the replication and stability of the plasmid, thereby affecting the expression effect. In vitro catalytic synthesis of cyclotides by biological methods, in addition to simplifying the experimental steps, also has the advantages of fast reaction speed, strong controllability, few by-products and high flexibility.

[0004] In summary, the existing methods for preparing Pseudostellariae cyclotide B include natural extraction method with many steps, high cost, and limited resources; chemical synthesis method with complicated steps, requiring the use of a large amount of organic reagents, which does not conform to the concept of green environmental protection; biological in vivo synthesis is easily limited by cell activity and complexity, and is often accompanied by the generation of by-products. Therefore, a simple, fast, high-yield, and high-purity preparation method of Pseudostellariae cyclotide B is urgently needed. Summary of the invention

[0005] The present invention aims to provide a method for preparing Pseudostellariae cyclopeptide B, so as to solve the technical problems of complicated steps, low purity, low yield and the like.

[0006] The purpose of the first aspect of the present invention is to provide a method for preparing Pseudostellaria baicalensis cyclic peptide B.

[0007] In order to achieve the above object, the technical solution adopted by the present invention is:

[0008] The first aspect of the present invention provides a method for preparing Pseudostellariae cyclopeptide B, comprising the following steps:

[0009] The linear Pseudostellariae cyclic peptide B (prehHB) and the cyclase GmPOPB were mixed and subjected to in vitro enzymatic reaction to obtain Pseudostellariae cyclic peptide B (cyclic peptide HB).

[0010] In some embodiments of the present invention, the concentration ratio of the linear Pseudostellaria heterophylla cyclopeptide B and the cyclase GmPOPB is 0.5 to 10:1.

[0011] In some embodiments of the present invention, the temperature of the in vitro enzymatic reaction is 15-50°C.

[0012] In some embodiments of the present invention, the reaction time of the in vitro enzymatic reaction is 0.5 to 24 hours.

[0013] In some embodiments of the present invention, the nucleotide sequence of the linear Pseudostigma cyclotide B is as shown in SEQ ID NO:1.

[0014] In some embodiments of the present invention, the nucleotide sequence of the cyclase GmPOPB is shown in SEQ ID NO:2.

[0015] In some embodiments of the present invention, the preparation method further comprises a step of removing impurities.

[0016] In some embodiments of the present invention, the impurity removal method includes any one of a heating treatment method, a methanol treatment method, and an extraction treatment method.

[0017] In some embodiments of the present invention, the heat treatment method comprises the following steps: after the exogenous enzymatic reaction is completed, heating the reaction system at 60-100° C. for 5-10 min.

[0018] The beneficial effects of the present invention are:

[0019] The present invention provides a preparation method for converting linear Pseudostellariae cyclopeptide B into cyclic Pseudostellariae cyclopeptide B only through an in vitro enzymatic reaction. The method can effectively solve the technical problems of complex preparation steps, low purity, low yield and the like of cyclic Pseudostellariae cyclopeptide B in the prior art, and can be used for large-scale preparation of cyclic Pseudostellariae cyclopeptide B with simple, low cost and short production cycle.

[0020] Specifically:

[0021] Strong controllability: Compared with traditional microbial fermentation, in vitro enzyme catalysis is not limited by cell activity and complexity. This means that reaction conditions such as temperature, time and substrate ratio can be more accurately controlled and adjusted, thereby optimizing the reaction process and improving product quality and yield.

[0022] Fast reaction speed: Since the in vitro enzyme catalysis system can remove many complex steps and regulatory mechanisms in cells, the reaction speed is usually faster than intracellular metabolism. This helps to shorten the production cycle and improve production efficiency.

[0023] Fewer side reactions: The in vitro enzyme catalysis system can more precisely control the reaction path and reduce unnecessary side reactions, thereby improving the purity and yield of the target product.

[0024] Environmental protection: The present invention utilizes biosynthesis technology to form Pseudostellaria heterophylla cyclic peptide B. Compared with chemical synthesis methods, it does not require the use of a large amount of chemical reagents and is more environmentally friendly. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 It is an SDS-PAGE electrophoresis diagram, in which lane 1 is a marker, lane 2 is prehHB total protein, lane 3 is prehHB soluble protein, lane 4 is prehHB purified protein, lane 5 is GmPOPB total protein, lane 6 is GmPOPB soluble protein, and lane 7 is GmPOPB purified protein.

[0026] Figure 2 It is an SDS-PAGE electrophoresis diagram, in which lane 1 is a marker, lane 2 is TEV, lane 3 is prehHB without enzyme digestion, lane 4 is the component after prehHB digestion, lane 5 is GmPOPB without enzyme digestion, and lane 6 is the component after GmPOPB digestion.

[0027] Figure 3 This is the purity result of the prepared Pseudostellariae Cyclic Peptide B. In the figure, the red color is the HPLC chart of the in vitro enzymatic reaction product after heating, and the blue color is the negative control (the solution without GmPOPB and containing prehHB in the in vitro enzymatic reaction).

[0028] Figure 4 The prepared Pseudostellariae cyclotide B (molecular formula C 40 H 58 N 8 O 8 )’s mass spectrum.

[0029] Figure 5 This is the standard curve result diagram for the detection of Pseudoradix Pseudoradix cyclotide B concentration.

[0030] Figure 6 The effect of time on in vitro enzymatic reaction.

[0031] Figure 7 The effect of temperature on in vitro enzymatic reactions.

[0032] Figure 8The effect of the ratio of prehHB to GmPOPB on the in vitro enzymatic reaction. DETAILED DESCRIPTION

[0033] The present invention is further described in detail below through specific examples.

[0034] It should be understood that these embodiments are only used to illustrate the present invention and are not used to limit the scope of the present invention.

[0035] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0036] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.

[0037] The first aspect of the present invention provides a method for preparing Pseudostellariae cyclopeptide B, comprising the following steps:

[0038] The linear Pseudostellariae cyclopeptide B (prehHB) and the cyclase GmPOPB are mixed and subjected to in vitro enzymatic reaction to obtain Pseudostellariae cyclopeptide B.

[0039] The cyclase GmPOPB used in the present invention is a multifunctional cyclase found in Amanita phalloides (scientific name: Galerina marginata), has strong enzyme activity and high substrate conversion rate.

[0040] The present invention clones and expresses prehHB and cyclase GmPOPB, and purifies them by affinity chromatography to obtain prehHB and cyclase GmPOPB. Those skilled in the art will undoubtedly know that prehHB and cyclase GmPOPB can be obtained by methods other than the method used in the present invention, and the obtained prehHB and cyclase GmPOPB can also be used to prepare cyclic peptide HB by the preparation method provided by the present invention.

[0041] In some embodiments of the present invention, the concentration ratio of the linear Pseudostellaria heterophylla cyclopeptide B and the cyclase GmPOPB is 0.5 to 10:1.

[0042] In some preferred embodiments of the present invention, the concentration ratio of the linear Pseudostellaria heterophylla cyclopeptide B and the cyclase GmPOPB is 2 to 9:1.

[0043] In some more preferred embodiments of the present invention, the concentration ratio of the linear Pseudostellariae cyclopeptide B and the cyclase GmPOPB is 3 to 8:1.

[0044] In some optimal embodiments of the present invention, the concentration ratio of the linear Pseudostellaria heterophylla cyclopeptide B and the cyclase GmPOPB is 6:1.

[0045] In some embodiments of the present invention, the temperature of the in vitro enzymatic reaction is 15-50°C.

[0046] In some preferred embodiments of the present invention, the temperature of the in vitro enzymatic reaction is 20-50°C.

[0047] In some more preferred embodiments of the present invention, the temperature of the in vitro enzymatic reaction is 20-40°C.

[0048] In some embodiments of the present invention, the reaction time of the in vitro enzymatic reaction is 0.5 to 24 hours.

[0049] In some preferred embodiments of the present invention, the reaction time of the in vitro enzymatic reaction is 1 to 15 hours.

[0050] In some more preferred embodiments of the present invention, the reaction time of the in vitro enzymatic reaction is 1 to 10 hours.

[0051] In some more preferred embodiments of the present invention, the reaction time of the in vitro enzymatic reaction is 1 to 6 hours.

[0052] In some embodiments of the present invention, the nucleotide sequence of the linear Pseudostigma cyclotide B is as shown in SEQ ID NO:1.

[0053] In some embodiments of the present invention, the nucleotide sequence of the cyclase GmPOPB is shown in SEQ ID NO:2.

[0054] In some embodiments of the present invention, the preparation method further comprises a step of removing impurities.

[0055] In some embodiments of the present invention, the impurity removal method includes any one of a heating treatment method, a methanol treatment method, and an extraction treatment method.

[0056] In some embodiments of the present invention, the heat treatment method comprises the following steps: after the exogenous enzymatic reaction is completed, heating the reaction system at 60-100° C. for 5-10 min.

[0057] In some preferred embodiments of the present invention, the heat treatment method comprises the following steps: after the exogenous enzymatic reaction is completed, heating the reaction system at 80-100° C. for 5-10 min.

[0058] In some embodiments of the present invention, the methanol treatment method is to add methanol to the reaction system after the outward enzymatic reaction is completed, the volume fraction of methanol is 10% to 70%, and the treatment time is 5 to 60 minutes.

[0059] In some embodiments of the present invention, the extraction treatment method comprises: using ethyl acetate to extract the reaction system after the external enzymatic reaction is completed, and the extraction time is 20 to 40 minutes.

[0060] Example 1 Preparation of linear Pseudostellaria heterophylla cyclic peptide B (prehHB) and cyclase GmPOPB

[0061] This embodiment provides a method for preparing linear Pseudostellaria heterophylla cyclic peptide B (prehHB) and cyclase GmPOPB, which specifically comprises the following steps:

[0062] 1. Construction of expression vector

[0063] (1) Construction of pMAL-C5X-TEV site-prehHB and pMAL-C5X-TEV site-GmPOPB expression vectors

[0064] The gene sequences of prehHB (nucleotide sequence such as SEQ ID NO: 1) and GmPOPB (nucleotide sequence such as SEQ ID NO: 2) were submitted to Beijing BGI Co., Ltd. for artificial synthesis, and digested with sac I and EcoR I to obtain the target gene after digestion; the sequence fragments were then inserted into the prokaryotic expression vector pMAL-C5X-TEVsite using the In-Fusion homologous recombination method to obtain plasmids pMAL-C5X-TEV site-prehHB and pMAL-C5X-TEV site-GmPOPB. The plasmids were sent for sequencing and the correct plasmids were saved.

[0065] ATGTTTGATACCAACGCGACCCGCCTGCCGATTTTTGGGGGTCTCCTCCTCCT TGGACCGCGGAACATGTGGATCAGACCCTGGCGAGCGGCAACGATATTTGCTAA (SEQ ID NO: 1).

[0066]

[0067] (2) Construction of engineered bacteria containing pMAL-C5X-TEV site-prehHB and pMAL-C5X-TEV site-GmPOPB plasmids

[0068] The plasmids pMAL-C5X-TEV site-prehHB and pMAL-C5X-TEV site-GmPOPB obtained in the above step (1) are transformed into the Escherichia coli BL21 (DE3) expression strain, screened by ampicillin (Amp) plates, and verified by sequencing to obtain an engineered strain containing the pMAL-C5X-TEV site-prehHB and pMAL-C5X-TEV site-GmPOPB plasmids.

[0069] 2. Induced expression of prehHB and GmPOPB proteins

[0070] Take the monoclonal strain verified by sequencing (engineered strain of pMAL-C5X-TEV site-prehHB / pMAL-C5X-TEV site-GmPOPB plasmid) in 5 mL of LB liquid medium (containing 50 mg / L Amp), place it in a constant temperature shaker at 37°C and 225 rpm for overnight culture, add the bacterial liquid to 300 mL of LB liquid medium containing 50 mg / L (50-100 mg / L) of antibiotic Amp at a ratio of 1:100, and continue to culture in a constant temperature shaker at 37°C and 225 rpm until OD 600 The value is between 0.4 and 0.6, add IPTG with a final concentration of 0.5mM (0.1-1mM is acceptable), place it in a constant temperature shaker at 25℃ (16-37℃ is acceptable), 180rpm (160-225rpm is acceptable) for induction culture for 16h (16-20h is acceptable), and collect the induced bacterial liquid.

[0071] 3. Purification and labeling of prehHB and GmPOPB proteins

[0072] (1) The induced bacterial solution collected in step 2 was centrifuged at 4°C, 8000 rpm for 5 min, the supernatant was discarded, and the bacterial cells were retained.

[0073] (2) Add the bacteria to 20 mL of binding buffer (20 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.4), resuspend and place in a beaker filled with ice, and disrupt using an ultrasonic cell disruptor (operating for 2 s, resting for 2 s, power 30%, 10 min) to obtain a total protein solution.

[0074] (3) The total protein solution after disruption was centrifuged at 4°C, 12,000 rpm for 20 min, and the supernatant protein was collected.

[0075] (4) Purify the target protein using Dextrin Beads 6FF purification column (Changzhou Tiandi Renhe Biotechnology Co., Ltd.) for purifying MBP-tagged proteins. The steps are: column equilibration - sample loading - protein washing - target protein elution - column washing - column preservation with 20% ethanol. The buffer for equilibration of the column and washing of impurities is binding buffer, and the buffer for eluting the target protein is maltose buffer (10mM Maltose, 20mM Tris-HCl, 200mM NaCl, 1mM EDTA, 1mM DTT, pH 7.4). The target proteins (prehHB and GmPOPB) were collected and placed on ice for later use.

[0076] (5) According to the operating procedures of the kit (Tiangen BCA Protein Quantification Kit (PA115)), the concentrations of protein prehHB and GmPOPB were determined, and TEV enzyme was added at a ratio between 1:50 and 1:150. The enzyme was digested at 4°C overnight to obtain linear Pseudomonas aeruginosa cyclopeptide B (prehHB) and cyclase GmPOPB.

[0077] The protein purification was detected by SDS-PAGE. Specifically, polyacrylamide gel electrophoresis (SDS-PAGE) was used to visualize whether the protein band sizes of prehHB and GmPOPB were correct. SDS-PAGE gel was prepared, and the sample to be tested (prehHB and GmPOPB prepared as described above) containing protein loading buffer was inactivated at 95-100°C, added to the loading well, and electrophoresed (two consecutive programs were set, namely, voltage 75V, 20min and voltage 150V, 40min), and then stained with Coomassie Brilliant Blue.

[0078] Test results such as Figure 1 and Figure 2 As shown in the figure, it can be seen that the protein band sizes of prehHB and GmPOPB after purification in this example are correct, that is, prehHB and GmPOPB are successfully prepared with high purity.

[0079] Example 2

[0080] A method for preparing Pseudostellariae cyclotide B (HB), comprising the following steps: adding equal concentrations (i.e., 1:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 30°C for 0.5 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0081] Example 3

[0082] A method for preparing Pseudostellariae cyclotide B (HB), comprising the following steps: adding equal concentrations (i.e., 1:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2 O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the condition of in vitro enzymatic reaction is 30°C for 1 h), and after the reaction is completed, heated (60-100°C, 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0083] Example 4

[0084] A method for preparing Pseudostellariae cyclotide B (HB), comprising the following steps: adding equal concentrations (i.e., 1:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2 O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 30°C for 2 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0085] Example 5

[0086] A method for preparing Pseudostellariae cyclotide B (HB), comprising the following steps: adding equal concentrations (i.e., 1:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2 O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 30°C for 4 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0087] Example 6

[0088] A method for preparing Pseudostellariae cyclotide B (HB), comprising the following steps: adding equal concentrations (i.e., 1:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 30°C for 6 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0089] Example 7

[0090] A method for preparing Pseudostellariae cyclotide B (HB), comprising the following steps: adding equal concentrations (i.e., 1:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2 O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 20°C for 2 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0091] Example 8

[0092] A method for preparing Pseudostellariae cyclotide B (HB), comprising the following steps: adding equal concentrations (i.e., 1:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2 O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 25°C for 2 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0093] Example 9

[0094] A method for preparing Pseudostellariae cyclotide B (HB), comprising the following steps: adding equal concentrations (i.e., 1:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2 O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 35°C for 2 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0095] Example 10

[0096] A method for preparing Pseudostellariae cyclotide B (HB), comprising the following steps: adding equal concentrations (i.e., 1:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 40°C for 2 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove the protein, thereby obtaining Pseudostellariae cyclotide B.

[0097] Embodiment 11

[0098] A method for preparing heterophyllotoxin cyclic peptide B (HB), comprising the following steps: adding equal concentrations (i.e., 2:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2 O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 30°C for 2 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0099] Example 12

[0100] A method for preparing Pseudostellariae cyclotide B (HB), comprising the following steps: adding equal concentrations (i.e., 3:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2 O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 30°C for 2 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0101] Embodiment 13

[0102] A method for preparing heterophyllotoxin cyclic peptide B (HB), comprising the following steps: adding equal concentrations (i.e., 6:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2 O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 30°C for 2 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0103] Embodiment 14

[0104] A method for preparing heterophyllotoxin cyclic peptide B (HB), comprising the following steps: adding equal concentrations (i.e., 9:1) of prehHB and GmPOPB protein (prepared in Example 1) after enzyme digestion to a 1 mL reaction system, and heating the mixture with ddH 2O is added to 1 mL, mixed and subjected to in vitro enzymatic reaction (the conditions for in vitro enzymatic reaction are 30°C for 2 h), and after the reaction is completed, heated (60-100°C for 5-10 min) to remove proteins (including prehHB and GmPOPB), thereby obtaining Pseudostellariae cyclotide B.

[0105] Effect Example

[0106] 1. Determination of purity and concentration of Pseudostellaria heterophylla cyclic peptide B

[0107] Purity: The purity of the Pseudostellariae Cyclotide B prepared in Example 13 was tested using ultra-high performance liquid chromatography-triple quadrupole mass spectrometry, and the specific steps were as follows:

[0108] Ultra performance liquid chromatography-triple quadrupole mass spectrometry (Thermo Fisher) was used to detect Pseudo-P ...

[0109] The results are as follows Figure 3 As shown, after heating, the in vitro enzymatic reaction product contains only Pseudostellariae Cyclic Peptide B, but no prehHB and GmPOPB. The reasons are as follows: Pseudostellariae Cyclic Peptide B can withstand 100°C, while prehHB and GmPOPB are not resistant to high temperatures and will denature and precipitate, which can be removed by centrifugation. This indicates that the Pseudostellariae Cyclic Peptide B prepared by the preparation method of Example 12 has a higher purity. The purity of Pseudostellariae Cyclic Peptide B prepared in Examples 2 to 12 and Example 14 is the same as that in Example 13. The molecular weight of Pseudostellariae Cyclic Peptide B was further determined by ultra-high performance liquid chromatography-triple quadrupole mass spectrometry, and the results are shown in Figure 4 As shown, the molecular weight of Pseudostigma cyclotide B is 777.54, which is in line with expectations.

[0110] Concentration: The content of Pseudostellariae Cyclotide B prepared in Examples 2 to 14 was determined by the standard curve method, and the specific steps were as follows:

[0111] Weigh 1 mg of standard of Pseudostellariae cyclotide B accurately, dissolve it in chromatographic grade methanol and make up to volume in a 10 mL volumetric flask to prepare a 100 μg / mL mother solution, and use chromatographic grade methanol to prepare the mother solution into 50 μg / mL, 20 μg / mL, 10 μg / mL, 5 μg / mL, and 0 μg / mL in turn. Detect by HPLC (Ultra-high performance liquid chromatography-triple quadrupole mass spectrometry (Thermo Fisher) was used to detect Pseudostellariae cyclotide B, the chromatographic column was a C18 column, the mobile phase was aqueous solution and acetonitrile, the flow rate was 1 mL / min, and the ion source was selected as HESI in the mass spectrometry conditions; data acquisition was set to positive and negative scans, the first-level mass spectrometry full scan (Full Scan) mode, the scan range (m / z) was 100-1000; the collision energy (Collision Energy) was set to 5; other parameters such as ion source temperature, spray voltage and sheath gas were set to default), and the standard curve was drawn with concentration as the horizontal axis and peak area as the vertical axis ( Figure 5 ), calculate the concentration of Pseudo-P ...

[0112] Under the condition of temperature of 30°C, the reaction time was set to 0.5h (Example 2), 1h (Example 3), 2h (Example 4), 4h (Example 4) and 6h (Example 6), and the amount of product Pseudostigma cyclotide B was detected by HPLC. The results are as follows: Figure 6 As shown in the figure, it can be seen that the maximum amount of Pseudostellariae Cyclic Peptide B is prepared in Example 4 when the reaction time is 2h; under the condition of a reaction time of 2h, the reaction temperature is set to 20°C (Example 7), 25°C (Example 8), 30°C (Example 4), 35°C (Example 9) and 40°C (Example 10), and the amount of the product Pseudostellariae Cyclic Peptide B is detected by HPLC. The results are as follows Figure 7 As shown in the figure, it can be seen that the maximum amount of Pseudostellariae Cyclic Peptide B is prepared when the reaction is at 30°C (Example 4); under the conditions of optimal reaction time and temperature, the reaction ratio of prehHB to GmPOPB is 1:1 (Example 4), 2:1 (Example 11), 3:1 (Example 12), 6:1 (Example 13) and 9:1 (Example 14), and the amount of the product Pseudostellariae Cyclic Peptide B is detected by HPLC. The results are as follows: Figure 8 As shown in the figure, it can be seen that when the ratio of prehHB to GmPOPB is 6:1 (Example 13), the prepared Pseudostellariae cyclopeptide B is the largest.

[0113] The methods of Examples 2 to 14 were used to prepare Pseudostellariae Cyclic Peptide B, which was repeated three times. The concentration of Pseudostellariae Cyclic Peptide B was detected. The results are shown in Table 1. It can be seen from the table that the Pseudostellariae Cyclic Peptide B prepared by the method of the present invention has a high content and good repeatability.

[0114] Table 1 Concentration of Pseudostellariae Cyclopeptide B prepared in Examples 2 to 14

[0115]

[0116]

[0117] The embodiments of the present invention are described in detail above in conjunction with the accompanying drawings, but the present invention is not limited to the above embodiments. Various changes can be made within the knowledge of ordinary technicians in the relevant technical field without departing from the purpose of the present invention. In addition, the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.

Claims

1. A method for preparing Pseudostellariae cyclopeptide B, comprising the following steps: The linear Pseudostellariae cyclopeptide B and the cyclase GmPOPB are mixed and subjected to an in vitro enzymatic reaction to obtain the Pseudostellariae cyclopeptide B.

2. The preparation method according to claim 1, characterized in that: The concentration ratio of the linear Pseudostellaria heterophylla cyclopeptide B and the cyclase GmPOPB is 0.5-10:

1.

3. The preparation method according to claim 1, characterized in that: The temperature of the in vitro enzymatic reaction is 15-50°C.

4. The preparation method according to claim 1, characterized in that: The reaction time of the in vitro enzymatic reaction is 0.5 to 24 hours.

5. The preparation method according to any one of claims 1 to 4, characterized in that: The nucleotide sequence of the linear Pseudostigma cyclopeptide B is shown in SEQ ID NO:

1.

6. The preparation method according to any one of claims 1 to 4, characterized in that: The nucleotide sequence of the cyclase GmPOPB is shown in SEQ ID NO:

2.

7. The preparation method according to any one of claims 1 to 4, characterized in that The preparation method further comprises an impurity removal step.

8. The preparation method according to claim 7, characterized in that: The impurity removal method includes any one of a heating treatment method, a methanol treatment method, and an extraction treatment method.

9. The preparation method according to claim 8, characterized in that: The heat treatment method comprises the following steps: after the exogenous enzymatic reaction is completed, the reaction system is heated at 60-100° C. for 5-10 minutes.

10. The preparation method according to claim 2, characterized in that: The concentration ratio of the linear Pseudostellaria heterophylla cyclopeptide B and the cyclase GmPOPB is 2 to 9:1.

Citation Information

Cited By

  • Application and synthesis method of cyclic peptide

    CN119818387A